HutchMED (China) LIMITED APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition
HutchMED (China) LIMITED (HCM) reported APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition of $11.76 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition · last filed 2026-03-05
- HutchMED (China) LIMITED apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2019-12-31 was $485.00K, a 65.53% increase year-over-year.
- HutchMED (China) LIMITED apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2019-09-30 was $460.00K, a 28.49% increase year-over-year.
- HutchMED (China) LIMITED apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2019-06-30 was $322.00K, a 34.95% decline year-over-year.
- HutchMED (China) LIMITED apic, share-based payment arrangement, other, increase for cost recognition for the quarter ending 2019-03-31 was $984.00K, a 52.85% decline year-over-year.
| Period end | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2025-12-31 | $11.76M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $7.81M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $27.25M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $19.46M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $23.61M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $13.81M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | $32.98M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | $23.69M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $19.88M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $13.13M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $7.22M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $5.21M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $485.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $945.00K derived: sum of 2 quarters · filed 2022-03-03 | $1.27M derived: sum of 3 quarters · filed 2022-03-03 | $2.25M 20-F · filed 2022-03-03 |
| 2019-09-30 | $460.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $782.00K derived: sum of 2 quarters · filed 2020-07-30 | $1.77M 6-K · filed 2020-01-21 | $2.06M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $322.00K derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $1.31M 6-K · filed 2020-07-30 | $1.60M derived: sum of 3 quarters · filed 2021-03-04 | $1.96M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $984.00K 6-K · filed 2019-06-06 | $1.28M derived: sum of 2 quarters · filed 2021-03-04 | $1.64M derived: sum of 3 quarters · filed 2021-03-04 | $2.13M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $293.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $651.00K derived: sum of 2 quarters · filed 2021-03-04 | $1.15M derived: sum of 3 quarters · filed 2021-03-04 | $3.23M 20-F · filed 2021-03-04 |
| 2018-09-30 | $358.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $853.00K derived: sum of 2 quarters · filed 2020-01-21 | $2.94M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $495.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $2.58M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $2.09M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $1.54M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $1.13M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $1.38M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $684.00K 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $233.00K 20-F · filed 2018-03-12 |